In cancer cells, a complex of c-Myc and c-Myc-interacting zinc finger protein-1 (Miz1) act on the promoter of p15 and p16, which, in turn, downregulates the expression of p15 and p16, enabling the cell to enter the cell cycle phases. The gene discussed is CDKN2A; the disease is cancer.